Neuromodulation

Neuromodulation refers to a physiological process in which a neuron uses chemical(s) to regulate a variety of neuronal populations. Discover the latest research on neuromodulation here.

July 7, 2020
Preprint

Deep Reinforcement Learning and its Neuroscientific Implications

ArXiv
Matthew BotvinickZeb Kurth-Nelson
July 6, 2020
Preprint
Open Access

A DNA-based optical nanosensor for in vivo imaging of acetylcholine in the peripheral nervous system

BioRxiv : the Preprint Server for Biology
J. XiaHeather A Clark
July 7, 2020

Ice coating -A new method of brain device insertion to mitigate acute injuries

Journal of Neuroscience Methods
Mohsin MohammedLina M E Pettersson
July 8, 2020

Interactive thyroid whole slide image diagnostic system using deep representation

Computer Methods and Programs in Biomedicine
Pingjun ChenPaul D Gader
July 8, 2020
Open Access

A mm-Sized Free-Floating Wireless Implantable Opto-Electro Stimulation Device

Micromachines
Yaoyao JiaMaysam Ghovanloo
July 9, 2020
Open Access

Response Variability in Transcranial Direct Current Stimulation: Why Sex Matters

Frontiers in Psychiatry
Thorsten RudroffJohn Kamholz
July 9, 2020
Open Access

Frameless stereotaxy in subthalamic deep brain stimulation: 3-year clinical outcome

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Carla PianoTommaso Tufo
July 6, 2020
Open Access

A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder

Nature Communications
Ningfei LiAndreas Horn
July 7, 2020

OSS-DBS: Open-source simulation platform for deep brain stimulation with a comprehensive automated modeling

PLoS Computational Biology
Konstantin ButenkoUrsula van Rienen
July 8, 2020
Open Access

Greater fatigability and motor unit discharge variability in human type 2 diabetes

Physiological Reports
Jonathon W SenefeldSandra K Hunter

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromodulation/d27b9ace-8b1e-4ab6-b16c-c2dcdf0c9922